#mindrank Tech News.
1 story in the last 7 days
The latest mindrank news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks mindrank across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
AIThe Next Webabout 2 hours ago
MindRank's oral GLP-1 reaches Phase III on $23MMindRank's MDR-001, an oral small-molecule GLP-1 receptor agonist, reached Phase III trials in about 4.5 years on roughly $23 million of research spending. The Hangzhou company closed a $52M Series B in July and runs the Molecule Arts AI platform. Clinical data remains unpublished.
Summaries by ByteBrief